Injecting slowly, using the proper needle gauge, and ensuring the solution is at room temperature (let the vial sit out for 15-20 minutes before injecting) can help minimize discomfort
International regulatory responses further validate these concerns the European Medicines Agency required gastroparesis warnings before the FDA, while Health Canada issued safety communications about GLP-1 gastrointestinal risks, demonstrating global recognition of this serious adverse effect
Versus semaglutide, tirzepatide 10 and 15 mg were associated with numerically higher odds of participants achieving 5%, 10% and 15% weight reduction, and statistically higher odds of participants achieving 20% weight reduction
This pattern has led obesity medicine experts to reconceptualize GLP-1 therapy as chronic maintenance treatment rather than a temporary intervention
Check to see if your health insurance plan covers Wegovy, the brand-name version of semaglutide thats approved for weight loss
Visit our bariatric specialist in the Brooklyn clinic to get professional medical help
